Close
Open Nav
Buzz of BIO

Congratulations to the 2017 winners!

Early Stage Entrepreneurs Late Stage Leaders Diagnostics and Beyond
Image result for Immune-Onc Therapeutics, Inc. Image result for Agile Sciences Inc 3i Diagnostics

 

Ten biotechs were nominated in each of the three categories, "Early Stage Entrepreneurs", "Late Stage Leaders" and "Diagnostics and Beyond". Please note that the contest is open to U.S. companies only.

  • To qualify for the Early Stage Entrepreneur Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues, and have raised less than $25 million USD as of July 1, 2017; have been founded after 2012; and have most recently completed either a Seed or Series A financing round. Companies that have previously presented at the BIO Investor Forum are not eligible for the Early Stage Entrepreneur category, but are welcome to apply under the Late Stage Leader category (if the company meets the minimum dollar requirements of the Late Stage Leader category).
  • To qualify for the Late Stage Leader Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues, and have raised more than $25 million USD as of July 1, 2017 and/or have been founded before 2012. 
  • To qualify for the Diagnostics and Beyond category, companies must be primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies. 

Read the official contest rules here.